Oxytocin receptor signalling.

[1]  F. Hirahara,et al.  Prospective study of intramuscular ergometrine compared with intramuscular oxytocin for prevention of postpartum hemorrhage , 2007, The journal of obstetrics and gynaecology research.

[2]  T. Reinheimer.  Barusiban suppresses oxytocin-induced preterm labour in non-human primates , 2007, BMC pregnancy and childbirth.

[3]  M. Bouvier,et al.  Distinct Signaling Profiles of β1 and β2 Adrenergic Receptor Ligands toward Adenylyl Cyclase and Mitogen-Activated Protein Kinase Reveals the Pluridimensionality of Efficacy , 2006, Molecular Pharmacology.

[4]  Larry J. Young,et al.  Neuropeptidergic regulation of affiliative behavior and social bonding in animals , 2006, Hormones and Behavior.

[5]  D. Devost,et al.  Oxytocin induces dephosphorylation of eukaryotic elongation factor 2 in human myometrial cells. , 2005, Endocrinology.

[6]  P. Cassoni,et al.  The Oxytocin Receptor Antagonist Atosiban Inhibits Cell Growth via a “Biased Agonist” Mechanism* , 2005, Journal of Biological Chemistry.

[7]  R. Lefkowitz,et al.  Differential Kinetic and Spatial Patterns of β-Arrestin and G Protein-mediated ERK Activation by the Angiotensin II Receptor* , 2004, Journal of Biological Chemistry.

[8]  A. Sapino,et al.  Oxytocin and Oxytocin Receptors in Cancer Cells and Proliferation , 2004, Journal of neuroendocrinology.

[9]  M. Francolini,et al.  Oxytocin receptor elicits different EGFR/MAPK activation patterns depending on its localization in caveolin-1 enriched domains , 2003, Oncogene.

[10]  Ming Yang,et al.  Extracellular signal-regulated kinase 1/2 activation by myometrial oxytocin receptor involves Galpha(q)Gbetagamma and epidermal growth factor receptor tyrosine kinase activation. , 2003, Endocrinology.

[11]  H. Zingg,et al.  The oxytocin receptor , 2003, Trends in Endocrinology & Metabolism.

[12]  C. Proud,et al.  Regulation of peptide-chain elongation in mammalian cells. , 2002, European journal of biochemistry.

[13]  Philip R. Cohen,et al.  Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway , 2001, FEBS letters.

[14]  G. Gimpl,et al.  The oxytocin receptor system: structure, function, and regulation. , 2001, Physiological reviews.

[15]  J. Copland,et al.  ERK2 mediates oxytocin-stimulated PGE2 synthesis. , 1998, American journal of physiology. Endocrinology and metabolism.

[16]  M. Karin.  The regulation of AP-1 activity by mitogen-activated protein kinases. , 1996, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[17]  C. Breton,et al.  Oxytocin receptor gene expression in the rat uterus during pregnancy and the estrous cycle and in response to gonadal steroid treatment. , 1995, Endocrinology.

[18]  M. Ohmichi,et al.  Oxytocin stimulates mitogen-activated protein kinase activity in cultured human puerperal uterine myometrial cells. , 1995, Endocrinology.

[19]  M. Phillippe.  Protein kinase C, an inhibitor of oxytocin-stimulated phasic myometrial contractions. , 1994, Biology of reproduction.

[20]  P. Husslein,et al.  Oxytocin receptors in the human uterus during pregnancy and parturition. , 1984, American journal of obstetrics and gynecology.

[21]  M. Soloff,et al.  Oxytocin receptors: triggers for parturition and lactation? , 1979, Science.

[22]  D. Devost,et al.  Oxytocin-induced activation of eukaryotic elongation factor 2 in myometrial cells is mediated by protein kinase C. , 2008, Endocrinology.

[23]  D. Devost,et al.  Novel in vitro system for functional assessment of oxytocin action. , 2007, American journal of physiology. Endocrinology and metabolism.

[24]  K. Morgan,et al.  ERK1/2-mediated phosphorylation of myometrial caldesmon during pregnancy and labor. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.